Loading...
ACTR-79. ESTABLISHMENT OF CLINICAL PROTOCOL TARGETING CANCER STEM CELLS IN RECURRENT GLIOBLASTOMA USING HIGH-THROUGHPUT DRUG SCREENING
Despite aggressive multimodal oncological treatment, glioblastoma (GBM) disease progresses within 10 months. Due to the lack of treatment options for the relapsed disease, enrollment in clinical trials may be the best option. However, the fundamental preclinical studies leading to clinical investiga...
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692302/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.066 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|